Viscosupplementation is the injection of hyaluronic acid is injected into diarthrodial joints to restore the rheological qualities of the synovial fluid and produce mechanical, analgesic, chondroprotective, and anti-inflammatory benefits. Healthcare professionals often choose viscosupplementation to treat osteoarthritis, but it may also be helpful for some individuals with other types of arthritis, like rheumatoid arthritis.
Minimally invasive delivery methods and longer-lasting formulations are just two innovations in viscosupplementation products that have emerged as major market trends, supporting growth.
Additionally, expanding treatment options through healthcare systems and retail clinics and growing public awareness of viscosupplementation’s effectiveness have been crucial in promoting market expansion. Thus, these types of treatments create a positive influence on the global viscosupplementation market.
According to a research report by Astute Analytica, the Global Viscosupplementation Market is growing at a compound annual growth rate (CAGR) of 8.4% over the projection period from 2023 to 2030.
Factors Affecting Market Growth
Osteoarthritis and Osteoporosis risks are rising
Osteoporosis is a bone disease that progresses due to decreased bone mass and mineral density, as well as other variations in the composition or structure of bone. Due to weakened bones, osteoporosis may increase the risk of fractures and shattered bones.
Compared to men, women are more likely to experience it. Osteoporosis often causes bone fractures in post-menstrual women since it is a silent illness with few signs and symptoms. Osteoporosis is mostly more common in older adults.
Osteoarthritis is a disease of the joints or an inflammation of the tissues close to the joints. Such conditions have an impact on a person’s movement.
Aging population growth
The number of old persons admitted to hospitals with fatal traumatic injuries rises in direct proportion to the population’s aging. The increased need for diagnosis and treatment is brought on by the rising prevalence of knee osteoarthritis illnesses. The demand for the healthcare system is growing as a result of the expanding population.
The need for care, services, and technology for the prevention and treatment of knee osteoarthritis disorders such as osteoporosis, osteopenia, sarcopenia, and other consequences proportionally increases with the need for the correct treatment.
These illnesses that cause brittle bones and joints are more common in the senior population. Viscosupplementation is applied during the treatment of such patients to give them quick and effective benefits related to their bodies.
Asia Pacific is anticipated to hold the biggest market share due to the increasing prevalence of osteoarthritis and the rising need for efficient, minimally invasive treatment.
Due to the rising need for osteoarthritis treatments, a rapidly aging population, and an increased knowledge of viscosupplementation, the area is also anticipated to develop at the fastest rate in the upcoming years.
A further factor projected to fuel market expansion in the Asia-Pacific region is the region with which rising healthcare spending and technological developments. Accordingly, the region is anticipated to keep providing more than 38% of the revenue generated by the Global Viscosupplementation Market.
North America is anticipated to take a close second place due to rising viscosupplementation knowledge and the accessibility of therapies through healthcare systems.
Original Source:- Viscosupplementation Market
Comments